3.4.2.0: Allergen immunotherapy

Part of chapter 3 Respiratory System, section 3.4 Antihistamines, hyposensitisation and allergic emergencies

High-level prescribing trends for Allergen immunotherapy (BNF section 3.4.2.0) across Rock Healthcare Limited for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Benralizumab (0304020AA)
House dust mites allergen extract (0304020AD)
Mepolizumab (0304020Y0)
Omalizumab (0304020X0)
Pollen allergy preparations (0304020P0)
Timothy grass pollen allergen extract (0304020AB)
Wasp and bee venom allergy preparations (0304020W0)
White Birch pollen allergen extract (0304020AC)
Feedback